Navigation Links
Verified Physicians a Must for Ensuring Quality Data From Online Surveys, Finds Frost & Sullivan
Date:1/27/2009

MOUNTAIN VIEW, Calif., Jan. 27 /PRNewswire/ -- As online physician panels gain popularity among pharmaceutical and medical device companies that conduct web-based surveys, research shows there is little interest to verify that the respondents in these surveys are indeed genuine physicians. This fraud can severely impact the quality of the data and compromise the integrity of the effort as the studies are only as good as their underlying respondents. It can also be costly for the study sponsors that base critical business decisions on these studies. Although some panel vendors make efforts to verify the identity of their physicians, it is the pharmaceutical marketing and brand managers who must increase their interest in this issue to force data quality standards.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Frost & Sullivan, the Growth Partnership Company, recently completed a whitepaper entitled Unmasking the Respondent: How to Ensure Genuine Physician Participation in an Online Panel that investigates the process of panel member verification for several key solution providers, including Epocrates, Medscape/WebMD and e-Rewards. This whitepaper reviews verification processes that impact the reliability of physician panels, including physician recruitment or opt-in participation, reliability and automation of the verification process, and disbursement of post-study honoraria.

"The pharmaceutical industry makes crucial business decisions on the basis of data obtained through online surveys of doctors," said Frost & Sullivan analyst Fernanda LopezAraujo. "So it was surprising for us to find how little consideration went into the verification of physicians used to generate this data by many of the companies funding the surveys."

"We have found some online panel vendors like Epocrates and Medscape/WebMD to be extremely conscientious about verifying their panelists' information against a credible source such as the American Medical Association database," continues LopezArauio. "Other vendors depend far more on self-reporting by physicians, and may not be as rigorous in imposing crucial checks on respondents who desire to participate in online surveys."

Pharmaceutical and medical device companies eventually pay for the online surveys; consequently, they also shoulder the responsibility to set expectations and ensure that best practices are followed in the industry. Market research managers from these companies should take an active role in the selection of a physician panel vendor that best meets their need for an online physician survey, and which also has a rigorous procedure for validating respondents.

If you are interested in receiving a copy of Unmasking the Respondent: How to Ensure Genuine Physician Participation in an Online Panel, please send an e-mail to Johanna Haynes, Corporate Communications, at johanna.haynes@frost.com with the following information: your full name, company name, title, company telephone number, company e-mail address, city, state, and country. We will send you the information via e-mail upon receipt of the above information.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

    Contact:
    Johanna Haynes
    Corporate Communications - North America
    P: 210.247.3870
    F: 210.348.1003
    E: johanna.haynes@frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IdentiGENs DNA TraceBack(R) Receives USDA Process Verified Program Approval
2. Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs
3. Broad-based group of physicians calls for improvement in stroke treatment
4. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
5. Psychiatrists are the least religious of all physicians
6. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
7. Scientists, physicians present latest findings in personalized cancer treatment and prevention
8. NNN Healthcare/Office REIT Acquires St. Mary Physicians Center in Long Beach, California
9. U.S. Physicians Question Presidential Candidates
10. New Jersey Physicians Launch New, Statewide Association to Fight for Stronger Voice in Healthcare
11. Internal medicine physicians recommend key elements to guide state initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... "Add realistic flares and light leaks to your ... clip to clip with high quality 4K lens flare footage," said Christina Austin - ... flares filmed on the RED Dragon. Utilizing the Dragon Sensor, TransFlare 4K Jewel lens ...
(Date:12/5/2016)... , ... December 05, 2016 , ... What: Shriners Hospitals ... the North Pole to our patients – using a video monitor and web-enabled camera. ... hospital will transform the Auditorium into a Christmas Wonderland, which is where the video ...
(Date:12/5/2016)... ... 05, 2016 , ... Edward Buckingham MD , and ... of the newest Sciton laser in January 2017. The Halo is the first ... ablative wavelengths for exceptional results. Outperforming more traditional lasers, the innovative Halo automatically ...
(Date:12/5/2016)... ... , ... For many years, Andrew G. Zubinas has accumulated over ... of the Lithuanian language and its poetry inspired him in writing “ ... explores all aspects of a living, breathing forest where nothing ever stays the same. ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... relationship-marketing firm, announced today that nominations will be accepted from December 5, ... Central Awards. , Awards include the Information Security Executive® of the Year, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 ... today announced preliminary safety and efficacy data from ... oral selective MDM2 inhibitor, suggesting that DS-3032 may ... relapsed/refractory acute myeloid leukemia (AML) and high-risk myelodysplastic ... part of the phase 1 study of DS-3032 were ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. announced ... the 2016 Annual Meeting of the American Epilepsy Society ... is indicated as an adjunctive therapy for the treatment ... generalized seizures and primary generalized tonic-clonic seizures (PGTC) in ... and older. Please see Important Safety Information for FYCOMPA, ...
(Date:12/5/2016)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... candidates, presents positive Phase 2a correlative data, as well as ... at the ongoing 58th American Society of Hematology (ASH) Annual ... . ... As previously announced, in ...
Breaking Medicine Technology: